Literature DB >> 20194437

A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity.

Sungchan Cho1, Gideon Dreyfuss.   

Abstract

Spinal muscular atrophy (SMA) is caused by homozygous survival of motor neurons 1 (SMN1) gene deletions, leaving a duplicate gene, SMN2, as the sole source of SMN protein. However, most of the mRNA produced from SMN2 pre-mRNA is exon 7-skipped ( approximately 80%), resulting in a highly unstable and almost undetectable protein (SMNDelta7). We show that this splicing defect creates a potent degradation signal (degron; SMNDelta7-DEG) at SMNDelta7's C-terminal 15 amino acids. The S270A mutation inactivates SMNDelta7-DEG, generating a stable SMNDelta7 that rescues viability of SMN-deleted cells. These findings explain a key aspect of the SMA disease mechanism, and suggest new treatment approaches based on interference with SMNDelta7-DEG activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194437      PMCID: PMC2827839          DOI: 10.1101/gad.1884910

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  32 in total

Review 1.  Spinal muscular atrophy.

Authors:  K Talbot; K E Davies
Journal:  Semin Neurol       Date:  2001-06       Impact factor: 3.420

2.  The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.

Authors:  Q Liu; U Fischer; F Wang; G Dreyfuss
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

3.  SMN oligomerization defect correlates with spinal muscular atrophy severity.

Authors:  C L Lorson; J Strasswimmer; J M Yao; J D Baleja; E Hahnen; B Wirth; T Le; A H Burghes; E J Androphy
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

4.  SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins.

Authors:  L Pellizzoni; B Charroux; G Dreyfuss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?

Authors:  K Talbot; C P Ponting; A M Theodosiou; N R Rodrigues; R Surtees; R Mountford; K E Davies
Journal:  Hum Mol Genet       Date:  1997-03       Impact factor: 6.150

6.  Carboxy-terminal determinants of intracellular protein degradation.

Authors:  D A Parsell; K R Silber; R T Sauer
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

7.  SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

Authors:  Thanh T Le; Lan T Pham; Matthew E R Butchbach; Honglai L Zhang; Umrao R Monani; Daniel D Coovert; Tatiana O Gavrilina; Lei Xing; Gary J Bassell; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2005-02-09       Impact factor: 6.150

8.  Emerging treatment options for spinal muscular atrophy.

Authors:  Barrington G Burnett; Thomas O Crawford; Charlotte J Sumner
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598

9.  Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo.

Authors:  Christopher R Heier; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

10.  Inactivation of the SMN complex by oxidative stress.

Authors:  Lili Wan; Elizabeth Ottinger; Sungchan Cho; Gideon Dreyfuss
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 19.328

View more
  97 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.

Authors:  Olga Tapia; Rocío Bengoechea; Ana Palanca; Rosa Arteaga; J Fernando Val-Bernal; Eduardo F Tizzano; María T Berciano; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2012-02-01       Impact factor: 4.304

Review 3.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

Review 4.  Spinal muscular atrophy: an update on therapeutic progress.

Authors:  Joonbae Seo; Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Biochim Biophys Acta       Date:  2013-08-27

5.  Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.

Authors:  Natalia N Singh; Brian M Lee; Ravindra N Singh
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

6.  TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.

Authors:  Natalia N Singh; Joonbae Seo; Eric W Ottesen; Maria Shishimorova; Dhruva Bhattacharya; Ravindra N Singh
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

7.  Monoubiquitination of survival motor neuron regulates its cellular localization and Cajal body integrity.

Authors:  Ke-Jun Han; Daniel Foster; Edward W Harhaj; Monika Dzieciatkowska; Kirk Hansen; Chang-Wei Liu
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

Review 8.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

10.  Small molecule screen reveals regulation of survival motor neuron protein abundance by Ras proteins.

Authors:  Reka R Letso; Andras J Bauer; Mitchell R Lunn; Wan Seok Yang; Brent R Stockwell
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.